(Q39615889)

English

Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes

scientific article published on 22 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

classical swine fever

1 reference

based on heuristic

inferred from title

classical swine fever virus

object named as

classical swine fever virus

1 reference

based on heuristic

inferred from title

Artur Summerfield

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

object named as

Nicolas Ruggli

6

0 references

author name string

Rolf Suter

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Lisa J Thomann-Harwood

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Kenneth C McCullough

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jon-Duri Tratschin

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

22 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1491-1503

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Alphavirus vectors and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Replication-defective viruses as vaccines and vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

The amino-terminal domain of bovine viral diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Classical Swine Fever Virus Interferes with Cellular Antiviral Defense: Evidence for a Novel Function of Npro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Classical Swine Fever Virus Npro Interacts with Interferon Regulatory Factor 3 and Induces Its Proteasomal Degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

The NPro Product of Bovine Viral Diarrhea Virus Inhibits DNA Binding by Interferon Regulatory Factor 3 and Targets It for Proteasomal Degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Classical Swine Fever Virus Can Remain Virulent after Specific Elimination of the Interferon Regulatory Factor 3-Degrading Function of Npro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Zinc binding in pestivirus N(pro) is required for interferon regulatory factor 3 interaction and degradation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Novel marker vaccines against classical swine fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Establishment and application of bicistronic classical swine fever virus genomes for foreign gene expression and complementation of E2 deletion mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Intermediate stages in monocyte-macrophage differentiation modulate phenotype and susceptibility to virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

C-kit positive porcine bone marrow progenitor cells identified and enriched using recombinant stem cell factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Generation of cytopathogenic subgenomic RNA of classical swine fever virus in persistently infected porcine cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Identification of conserved epitopes on a hog cholera virus protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Porcine bone marrow myeloid cells: phenotype and adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Heterogeneous expression of the non-structural protein p80/p125 in cells infected with different pestiviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Detection of antibodies against classical swine fever virus in swine sera by indirect ELISA using recombinant envelope glycoprotein E2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Quantitative analysis of the antigen-specific IFNgamma+ T cell-mediated immune response in conventional outbred pigs: kinetics and duration of the DNA-induced IFNgamma+ CD8+ T cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Construction of an infectious chimeric classical swine fever virus containing the 5′UTR of bovine viral diarrhea virus, and its application as a universal internal positive control in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Baculovirus expression and affinity purification of protein E2 of classical swine fever virus strain Alfort/187.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Type I interferons as vaccine adjuvants against infectious diseases and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Adjuvant activity of type I interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Improving vaccine delivery using novel adjuvant systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Cytokines as natural adjuvants for vaccines: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

"Self" and "Nonself" Manipulation of Interferon Defense during Persistent Infection: Bovine Viral Diarrhea Virus Resists Alpha/Beta Interferon without Blocking Antiviral Activity against Unrelated Viruses Replicating in Its Host Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Adjuvant activity of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Construction and characterization of subgenomic replicons of New York strain of West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Therapeutic and prophylactic applications of alphavirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

Characterization of an autonomous subgenomic pestivirus RNA replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Classical swine fever virus leader proteinase Npro is not required for viral replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Processing of pestivirus polyprotein: cleavage site between autoprotease and nucleocapsid protein of classical swine fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

N-terminal protease of pestiviruses: identification of putative catalytic residues by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant classical swine fever virus stably expresses a marker gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.12.026

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39615889&oldid=1845459068"